Skip to content
healthcare.dev

OGIVRI

NDC 83257-004, trastuzumab-dkst, kit, from Biocon Biologics Inc..

Product NDC
83257-004
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761074
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
83257-004-12832570004121 KIT in 1 CARTON (83257-004-12) * 20 mL in 1 VIAL, MULTI-DOSE (83257-003-11) * 20 mL in 1 VIAL (83257-002-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b6465b44-a6dd-f99c-d009-6851cf05169c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83257-004

Use it

Look up 83257-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.